The Company focuses on all aspects of a treatment cycle – pre-operative planning, intra-operative guidance, post-operative evaluation, and long-term continued care – across many medical specialties. M2S features PEMS, a secure, web-based system with pre-measured morphology calculations, graphs, images, and other time-saving tools to accurately and efficiently monitor patient condition.  FreshTracks Capital was part of a syndicate of investors which completed an investment during Q3 2003 in MMS. The company was successfully sold to a division of AIG Altaris Health Partners in September 2005.

Visit Medical Metrx Solutions